Rockwell Medical Technologies (RMTI) Misses Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $6.86 -2%
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Revenue Growth %: +14.9%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.05), $0.03 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $14.4 million versus the consensus estimate of $14.93 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ONEOK (OKE) Tops Q3 EPS by 63c; raises guidance
- Pacific Valley Bank (PVBK) Tops Q3 EPS by 24c
- The Ensign Group (ENSG) Tops Q3 EPS by 6c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
